Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline TGE Value Creative Solutions Corp BEBE Q3 2016 Earnings Steep EPS Miss Dampens Outlook OXLCN Q4 2025 Earnings EPS Misses Estimates Amid Stable Preferred Distribution Angel Studios Inc ANGX Q1 2026 Earnings Narrowing Losses Surprisedriven Stock Rally Root Inc ROOT Q1 2026 Earnings Massive EPS Beat as Underwriting Improvements Drive Profitability GLIBK Q1 2026 Earnings Significant EPS Miss Sends Stock Lower